loading
전일 마감가:
$121.45
열려 있는:
$122.49
하루 거래량:
287.71K
Relative Volume:
0.50
시가총액:
$6.04B
수익:
$338.46M
순이익/손실:
$-310.96M
주가수익비율:
-18.53
EPS:
-6.53
순현금흐름:
$-132.82M
1주 성능:
+1.85%
1개월 성능:
-0.26%
6개월 성능:
+8.33%
1년 성능:
+33.65%
1일 변동 폭
Value
$120.81
$124.53
1주일 범위
Value
$115.31
$124.53
52주 변동 폭
Value
$75.56
$139.13

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
명칭
Axsome Therapeutics Inc
Name
전화
(212) 332-3241
Name
주소
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Name
직원
589
Name
트위터
Name
다음 수익 날짜
2025-02-18
Name
최신 SEC 제출 서류
Name
AXSM's Discussions on Twitter

AXSM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AXSM
Axsome Therapeutics Inc
120.99 6.06B 338.46M -310.96M -132.82M -6.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
404.02 100.41B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.67 59.59B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.67 59.77B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
773.20 45.14B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
342.26 37.42B 3.81B -644.79M -669.77M -6.24

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-03 재개 Wells Fargo Overweight
2025-07-03 재개 Morgan Stanley Overweight
2025-06-03 개시 Oppenheimer Outperform
2025-04-07 개시 Jefferies Buy
2025-02-11 개시 Deutsche Bank Buy
2024-12-31 재확인 Mizuho Outperform
2024-09-03 개시 Wells Fargo Overweight
2024-08-06 업그레이드 BofA Securities Neutral → Buy
2024-07-22 개시 Needham Buy
2024-04-29 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-03-19 개시 Robert W. Baird Outperform
2024-02-06 개시 UBS Buy
2024-01-25 개시 RBC Capital Mkts Outperform
2023-12-13 개시 Citigroup Buy
2023-08-08 업그레이드 BofA Securities Underperform → Neutral
2023-01-05 개시 Piper Sandler Neutral
2022-11-01 개시 Loop Capital Buy
2022-09-07 재개 Mizuho Buy
2021-08-10 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-06-10 개시 Berenberg Buy
2021-01-08 개시 Jefferies Buy
2020-12-16 개시 Mizuho Buy
2020-09-29 개시 BofA Securities Underperform
2020-09-10 개시 Morgan Stanley Overweight
2020-04-28 재확인 H.C. Wainwright Buy
2020-04-14 개시 Cowen Outperform
2019-12-30 재확인 H.C. Wainwright Buy
2019-12-17 재확인 H.C. Wainwright Buy
2019-12-16 재확인 Guggenheim Buy
2019-10-16 개시 Guggenheim Buy
2019-09-18 개시 William Blair Outperform
2019-05-28 개시 SunTrust Buy
2019-05-23 재확인 H.C. Wainwright Buy
2019-04-08 개시 SVB Leerink Outperform
2019-03-15 재확인 H.C. Wainwright Buy
2016-10-03 재개 Brean Capital Buy
2015-12-15 개시 Cantor Fitzgerald Buy
2015-12-14 개시 Ladenburg Thalmann Buy
모두보기

Axsome Therapeutics Inc 주식(AXSM)의 최신 뉴스

pulisher
11:31 AM

AXSM: New 'Buy' Rating from B. Riley Securities with $179 PT | A - GuruFocus

11:31 AM
pulisher
10:04 AM

How Axsome Therapeutics Inc. (19X) stock trades after rate cuts2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com

10:04 AM
pulisher
06:38 AM

Will Axsome Therapeutics Inc. (19X) stock deliver stable dividendsJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com

06:38 AM
pulisher
Sep 30, 2025

H.C. Wainwright maintains Axsome stock Buy rating, $190 target - MSN

Sep 30, 2025
pulisher
Sep 30, 2025

Can Auvelity Drive Axsome's Growth Through the Rest of 2025? - The Globe and Mail

Sep 30, 2025
pulisher
Sep 30, 2025

Obstructive Sleep Apnea Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Apnimed, Eli Lilly and Company, Axsome Therapeutics/Jazz Pharmaceuticals, Bioprojet Pharma - Barchart.com

Sep 30, 2025
pulisher
Sep 30, 2025

Obstructive Sleep Apnea Market Insights Highlight Expanding - openPR.com

Sep 30, 2025
pulisher
Sep 30, 2025

Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - Mitrade

Sep 30, 2025
pulisher
Sep 30, 2025

Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - The Motley Fool

Sep 30, 2025
pulisher
Sep 29, 2025

Axsome Sues Apotex to Block Copies of Symbravo Migraine Drug - Bloomberg Law News

Sep 29, 2025
pulisher
Sep 29, 2025

Can Axsome Therapeutics Inc. stock withstand economic slowdownJuly 2025 Recap & Pattern Based Trade Signal System - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Axsome Therapeutics Inc. (19X) stock outperform global peers2025 Top Gainers & Real-Time Market Trend Scan - newser.com

Sep 29, 2025
pulisher
Sep 24, 2025

Axsome Therapeutics ($AXSM) Is Paying a $7.75M Settlement to Investors — Here’s How to Get Your Shar - TradingView

Sep 24, 2025
pulisher
Sep 23, 2025

Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $148 - 富途牛牛

Sep 23, 2025
pulisher
Sep 23, 2025

Axsome Settles Investors' Drug Approval Suit For $7.8M - Law360

Sep 23, 2025
pulisher
Sep 23, 2025

Axsome Therapeutics ($AXSM) $7.75M Investor Settlement - TradingView

Sep 23, 2025
pulisher
Sep 23, 2025

Axsome Therapeutics and $AXSM Investors Finalise $7.75M Settlement Agreement - TradingView

Sep 23, 2025
pulisher
Sep 23, 2025

Cantor Fitzgerald Has Weak Forecast for AXSM FY2026 Earnings - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Assenagon Asset Management S.A. Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Axsome therapeutics COO Jacobson sells $1.15 million in shares By Investing.com - Investing.com Canada

Sep 23, 2025
pulisher
Sep 22, 2025

Axsome therapeutics COO Jacobson sells $1.15 million in shares - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

Axsome Therapeutics (NASDAQ:AXSM) COO Mark L. Jacobson Sells 10,000 Shares - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Axsome to Settle Class Suit Over Migraine Drug for $7.75 Million - Bloomberg Law News

Sep 22, 2025
pulisher
Sep 22, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Buy" by Analysts - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Axsome Therapeutics (NASDAQ:AXSM) COO Sells $5,241,237.84 in Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Pallas Capital Advisors LLC Purchases 2,492 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

10,400 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Strs Ohio - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Herriot Tabuteau Sells 15,254 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Herriot Tabuteau Sells 27,907 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Herriot Tabuteau Sells 19,719 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Market Moves: Can Axsome Therapeutics Inc. continue delivering strong returnsTrade Risk Assessment & Stepwise Swing Trade Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Intech Investment Management LLC Boosts Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

How Investors May Respond To Axsome Therapeutics (AXSM) Showcasing Late-Stage CNS Pipeline Data at Psych Congress - Yahoo Finance

Sep 20, 2025
pulisher
Sep 20, 2025

Voya Investment Management LLC Sells 3,742 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Tech Rally: How does Axsome Therapeutics Inc compare to its peers2025 Stock Rankings & Fast Momentum Entry Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

FY2026 EPS Estimates for AXSM Decreased by Cantor Fitzgerald - Defense World

Sep 19, 2025
pulisher
Sep 19, 2025

Rhumbline Advisers Has $6.39 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Axsome Therapeutics COO sells shares for $5.2 million By Investing.com - Investing.com Australia

Sep 18, 2025
pulisher
Sep 17, 2025

AQR Capital Management LLC Purchases 20,152 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

Sep 17, 2025

Axsome Therapeutics Inc (AXSM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.27
price up icon 2.83%
$86.65
price up icon 2.14%
$31.70
price up icon 3.28%
$101.93
price up icon 3.37%
$147.65
price up icon 2.68%
biotechnology ONC
$342.17
price up icon 0.72%
자본화:     |  볼륨(24시간):